CDTX vs MPC · rev $1.3M vs P/E 16, rev $138.86B
Cidara Therapeutics Inc (CDTX) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
CDTX currently screens at market cap $6.96B. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the CDTX and MPC stock pages for the full models.
Not investment advice.